Severity of major depression features have also been associated with inflammatory biomarkers, including IL-6, in cancer survivors [72], and our group has found that NF-κB activation in circulating immune cells is elevated in breast cancer survivors and is positively associated with fatigue and depression [55]. Here, NFKB1 is linked to depressive symptom measurement.